Skip to main content
Journal cover image

Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer.

Publication ,  Journal Article
Suzuki, Y; Chen, L; Matsuo, K; Ferris, JS; Elkin, EB; Melamed, A; Kong, CY; Bickell, N; Myers, ER; Havrilesky, LJ; Xu, X; Blank, SV ...
Published in: Gynecol Oncol
November 2024

OBJECTIVE: Although obesity is an important risk factor for endometrial intraepithelial neoplasia (EIN) and uterine cancer, little is known about the trends in use of weight-loss therapy for patients with obesity with EIN and uterine cancer. We examined the use of weight-loss therapy among patients with obesity with EIN and uterine cancer. METHODS: The Merative MarketScan Database was used to identify patients aged 18-70 years who were obese and diagnosed with EIN or uterine cancer. The primary treatment for EIN or uterine cancer was categorized as either primary hysterectomy or hormonal therapy. Nutrition counseling, bariatric surgeries, and weight-management medications were identified as weight-loss therapy. We analyzed trends in the use of any weight-loss therapies with Cochran-Armitage tests. A multivariable logistic regression model was developed to examine factors associated with weight-loss therapy use. RESULTS: Overall, 15,374 patients were identified, including 5561 (36.2%) patients with EIN and obesity, and 9813 (63.8%) patients with uterine cancer and obesity. Weight-loss therapy was utilized within 1 year after diagnosis in 480 (8.6%) patients with EIN and in 802 (8.2%) patients with uterine cancer. Use of any weight-loss therapy after diagnosis of EIN increased from 4.1% in 2009 to 12.6% in 2020 (P < .001), and the use of any weight-loss therapy after diagnosis of uterine cancer increased from 4.9% in 2009 to 11.4% in 2020 (P < .001). In a multivariable regression model, younger age and patients with high comorbidity score were associated with a higher likelihood of using any weight-loss therapy. CONCLUSIONS: Use of weight-loss therapy has increased, however there is still a significant underuse of this adjunctive therapy in patients with obesity with EIN or uterine cancer.

Duke Scholars

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

November 2024

Volume

190

Start / End Page

78 / 83

Location

United States

Related Subject Headings

  • Young Adult
  • Weight Loss
  • Uterine Neoplasms
  • Oncology & Carcinogenesis
  • Obesity
  • Middle Aged
  • Humans
  • Female
  • Endometrial Neoplasms
  • Carcinoma in Situ
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Suzuki, Y., Chen, L., Matsuo, K., Ferris, J. S., Elkin, E. B., Melamed, A., … Wright, J. D. (2024). Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecol Oncol, 190, 78–83. https://doi.org/10.1016/j.ygyno.2024.08.003
Suzuki, Yukio, Ling Chen, Koji Matsuo, Jennifer S. Ferris, Elena B. Elkin, Alexander Melamed, Chung Yin Kong, et al. “Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer.Gynecol Oncol 190 (November 2024): 78–83. https://doi.org/10.1016/j.ygyno.2024.08.003.
Suzuki Y, Chen L, Matsuo K, Ferris JS, Elkin EB, Melamed A, et al. Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecol Oncol. 2024 Nov;190:78–83.
Suzuki, Yukio, et al. “Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer.Gynecol Oncol, vol. 190, Nov. 2024, pp. 78–83. Pubmed, doi:10.1016/j.ygyno.2024.08.003.
Suzuki Y, Chen L, Matsuo K, Ferris JS, Elkin EB, Melamed A, Kong CY, Bickell N, Myers ER, Havrilesky LJ, Xu X, Blank SV, Hazelton WD, Hershman DL, Wright JD. Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecol Oncol. 2024 Nov;190:78–83.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

November 2024

Volume

190

Start / End Page

78 / 83

Location

United States

Related Subject Headings

  • Young Adult
  • Weight Loss
  • Uterine Neoplasms
  • Oncology & Carcinogenesis
  • Obesity
  • Middle Aged
  • Humans
  • Female
  • Endometrial Neoplasms
  • Carcinoma in Situ